Ultragenyx CFO (RARE) sells $155,644 in company shares

Howard Horn, CFO of Ultragenyx Pharmaceutical (RARE), sold $155,644 worth of company shares. The transaction involved a sizable number of shares, indicating insider activity. Insider selling can sometimes raise questions about a company's future prospects. Such transactions are monitored by investors as they may signal potential shifts in company performance or management confidence. This matters for ordinary investors as it reflects decision-making at the executive level regarding Ultragenyx's current valuation and outlook.